People · Operator

Josh Becker

Named in public records as an officer, director or promoter · active 2011–2021 · Energy / Climate, Pharma

2
Companies
9
Filings
$30.9M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
People Power CoEnergy / ClimateSeries A$17.3M$45.4M2011
RadImmune Therapeutics, Inc.PharmaSeries A$13.6M$420.0M2019
Operator network

Josh Becker at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

David Lee · 15 companies · 1 sharedDavid LeeDavid Moss · 5 companies · 1 sharedDavid MossDavid R. Lee · 5 companies · 1 sharedDavid R. LeeBenjamin Black · 4 companies · 1 sharedBenjamin BlackCharles Finnie · 4 companies · 1 sharedCharles FinnieSTEPHEN F. WIGGINS · 2 companies · 1 sharedSTEPHEN F. WIGGINSStephen Wiggins · 2 companies · 1 sharedStephen WigginsGene Wang · 1 companies · 1 sharedGene WangGregory McCarthy · 1 companies · 1 sharedGregory McCarthyLisa R. D'Alencon · 1 companies · 1 sharedLisa R. D'AlenconWill Graylin · 1 companies · 1 sharedWill GraylinJack Hidary · 3 companies · 1 sharedJack HidaryRon Lennox · 1 companies · 1 sharedRon LennoxPeople Power Co · $17.3M raisedPeople Power CoRadImmune Therapeutics, Inc. · $13.6M raisedRadImmune Therapeutic…Josh BeckerJB
Josh Becker Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Josh Becker on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
David Lee115
David R. Lee15
David Moss15
Charles Finnie14
Benjamin Black14
Jack Hidary13
Stephen Wiggins12
STEPHEN F. WIGGINS12
Lisa R. D'Alencon11
Will Graylin11
Gene Wang11
Gregory McCarthy11
Ron Lennox11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.